epro-995x60.png
FEATURED ARTICLES
-
FDA's Draft Guidance On Bayesian Methods: Strategic Implications For Small Biotechs
The FDA draft guidance on Bayesian methodology represents a major validation of statistical innovation in clinical development. Jessica Cordes summarizes the latest from the FDA and offers advice for small biotechs.
-
How Regulatory Convergence Is Rewriting Clinical Data Management
Regulatory shifts toward structured, digital clinical trial protocols are reducing manual interpretation, enabling risk-based oversight, and supporting more efficient, transparent, end-to-end trial execution.
-
Sponsor-Provided Source Templates: Your Questions Answered
See how centralized eSource improves trial operations through faster startup, better data quality, and real‑time protocol guidance. An expert Q&A offers practical tips for sponsors, sites, and CROs.
WHITE PAPERS AND CASE STUDIES
-
Streamline Data Capture And Automate EHR-To-EDC Data Transfer
Streamline clinical trials by automating data transfer from EHRs to EDCs. Reduce site burden, minimize manual entry errors, and accelerate timelines to get critical insights faster.
-
The Definitive Infrastructure For Modern Drug Development
Modernize clinical trials with AI-powered recruitment and automated EHR data capture to accelerate enrollment, improve data quality, and expand patient access across a global research network.
-
What Unified eCOA And IRT Can Unlock
See how real-time scoring and automated eligibility checks helped a global dermatology study reduce site burden, avoid manual errors, and move participants through screening with greater speed.
NEWS
- AI Agent Enhances Principal Investigator Oversight Of eCOA Data
- Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes
- Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
- Exco InTouch Joins Critical Path Institute ePRO Consortium To Advance Electronic Data Capture In Clinical Trials
- ERT Expands Corporate Presence In Japan